Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Amiodarone — an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine

Identifieur interne : 003359 ( Main/Exploration ); précédent : 003358; suivant : 003360

Amiodarone — an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine

Auteurs : Nisar A. Shaikh [Canada] ; Eugene Downar [Canada] ; Jagdish Butany [Canada]

Source :

RBID : ISTEX:FBB5BAE4DE480A524BAE62C540F26AAAB94B5FA1

English descriptors

Abstract

Abstract: Amiodarone, an antiarrhythmic drug, like chloroquine and chlorpromazine, is a tertiary amine with amphiphilic properties. Chloroquine and chlorpromazine are known inhibitors of phospholipases. All three drugs produce characteristic microcorneal deposits consistent with lysosomal accumulations of phospholipid. Similar lysosomal bodies were found in leukocytes of 15 patients on chronic amiodarone treatment as well as 3 patients each on chloroquine and chlorpromazine, suggestive of widespread systemic inhibition of lysosomal phospholipases. These lysosomal inclusions were similar in morphology, irrespective of the drug given, and were of four types: multilamellar, amorphous dense, amorphous light, or a combination of 2 or more of the preceding types. There was no simple relationship between the number of inclusion bodies per cell and the cumulative dose of amiodarone (r=0.02) or amiodarone serum levels (r=0.11). An in vitro assay was used to compare the effects of the three drugs on Ca2+-dependent phospholipase A and C activities. Phospholipase A2 activity was inhibited in a dose-dependent fashion (1–8 mg/assay) by all three drugs in the order: chlorpromazine > amiodarone > chloroquine. The inhibitory effect on phospholipase C was more pronounced with all three drugs, producing almost total inhibition at 8 mg/assay. In a Ca2+-independent lysosomal phospholipase A system, amiodarone had a greater effect, producing 85% inhibition at 1.2 mg/assay. These observations suggest that amiodarone, like other cationic amphiphiles, induces a generalized phospholipidosis by inhibiting phospholipid catabolism. Its therapeutic and toxic effects may be due to its ability to modulate both Ca2+-dependent membrane phospholipases and Ca2+-independent acid phospholipases.

Url:
DOI: 10.1007/BF00223481


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Amiodarone — an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine</title>
<author>
<name sortKey="Shaikh, Nisar A" sort="Shaikh, Nisar A" uniqKey="Shaikh N" first="Nisar A." last="Shaikh">Nisar A. Shaikh</name>
</author>
<author>
<name sortKey="Downar, Eugene" sort="Downar, Eugene" uniqKey="Downar E" first="Eugene" last="Downar">Eugene Downar</name>
</author>
<author>
<name sortKey="Butany, Jagdish" sort="Butany, Jagdish" uniqKey="Butany J" first="Jagdish" last="Butany">Jagdish Butany</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FBB5BAE4DE480A524BAE62C540F26AAAB94B5FA1</idno>
<date when="1987" year="1987">1987</date>
<idno type="doi">10.1007/BF00223481</idno>
<idno type="url">https://api.istex.fr/ark:/67375/1BB-S4HWG393-B/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000477</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000477</idno>
<idno type="wicri:Area/Istex/Curation">000477</idno>
<idno type="wicri:Area/Istex/Checkpoint">002118</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002118</idno>
<idno type="wicri:doubleKey">0300-8177:1987:Shaikh N:amiodarone:an:inhibitor</idno>
<idno type="wicri:Area/Main/Merge">003431</idno>
<idno type="wicri:Area/Main/Curation">003359</idno>
<idno type="wicri:Area/Main/Exploration">003359</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Amiodarone — an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine</title>
<author>
<name sortKey="Shaikh, Nisar A" sort="Shaikh, Nisar A" uniqKey="Shaikh N" first="Nisar A." last="Shaikh">Nisar A. Shaikh</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Departments of Medicine & Clinical Biochemistry, University of Toronto, MSS 1A8, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Downar, Eugene" sort="Downar, Eugene" uniqKey="Downar E" first="Eugene" last="Downar">Eugene Downar</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Medicine, University of Toronto, & Women's College Hospital, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Butany, Jagdish" sort="Butany, Jagdish" uniqKey="Butany J" first="Jagdish" last="Butany">Jagdish Butany</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pathology, University of Toronto, & Toronto General Hospital, Toronto</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Molecular and Cellular Biochemistry</title>
<title level="j" type="sub">An International Journal for Chemical Biology in Health and Disease</title>
<title level="j" type="abbrev">Mol Cell Biochem</title>
<idno type="ISSN">0300-8177</idno>
<idno type="eISSN">1573-4919</idno>
<imprint>
<publisher>Kluwer Academic Publishers</publisher>
<pubPlace>Dordrecht</pubPlace>
<date type="published" when="1987-08-01">1987-08-01</date>
<biblScope unit="volume">76</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="163">163</biblScope>
<biblScope unit="page" to="172">172</biblScope>
</imprint>
<idno type="ISSN">0300-8177</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0300-8177</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>amiodarone</term>
<term>chloroquine</term>
<term>chlorpromazine</term>
<term>cytoplasmic inclusions</term>
<term>lysosomes</term>
<term>phospholipases</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Acid phospholipases</term>
<term>Alveolar macrophages</term>
<term>Amiodarone</term>
<term>Amiodarone serum levels</term>
<term>Amorphous light</term>
<term>Assay</term>
<term>Assay mixture</term>
<term>Assay tubes</term>
<term>Biochem pharmacol</term>
<term>Biochemical observations</term>
<term>Biochim biophys acta</term>
<term>Biol chem</term>
<term>Bovine liver</term>
<term>Buffy</term>
<term>Buffy coat preparations</term>
<term>Cationic</term>
<term>Cationic amphiphiles</term>
<term>Characteristic cytoplasmic inclusion bodies</term>
<term>Chloroquine</term>
<term>Chlorpromazine</term>
<term>Chronic amiodarone treatment</term>
<term>Chronic therapy</term>
<term>Chronic treatment</term>
<term>College hospital</term>
<term>Control activity</term>
<term>Cumulative dose</term>
<term>Cytoplasmic</term>
<term>Cytoplasmic inclusion bodies</term>
<term>Cytoplasmic inclusions</term>
<term>Downar</term>
<term>Generalized phospholipidosis</term>
<term>Higher concentrations</term>
<term>Inclusion</term>
<term>Inclusion bodies</term>
<term>Inhibition</term>
<term>Inhibitory effect</term>
<term>Inhibitory effects</term>
<term>Ischemia</term>
<term>Leukocyte</term>
<term>Lipid</term>
<term>Liver lysosomes</term>
<term>Lower phase</term>
<term>Lysosomal</term>
<term>Lysosomal accumulations</term>
<term>Lysosomal homogenate</term>
<term>Lysosomal inclusions</term>
<term>Lysosomal phospholipase</term>
<term>Lysosomal phospholipases</term>
<term>Lysosome</term>
<term>Macrophage</term>
<term>Membrane phospholipases</term>
<term>Membrane phospholipids</term>
<term>Myocardial ischemia</term>
<term>Normal individuals</term>
<term>Other cationic amphiphiles</term>
<term>Other drugs</term>
<term>Phospholipase</term>
<term>Phospholipase activities</term>
<term>Phospholipase activity</term>
<term>Phospholipases</term>
<term>Phospholipid</term>
<term>Phospholipid catabolism</term>
<term>Phospholipid losses</term>
<term>Phospholipidosis</term>
<term>Polymorphonuclear leukocytes</term>
<term>Reaction products</term>
<term>Shaikh</term>
<term>Sigma chemical</term>
<term>Simple relationship</term>
<term>Solvent front</term>
<term>Specific activity</term>
<term>Standard assay conditions</term>
<term>Tertiary amine</term>
<term>Total inhibition</term>
<term>Toxic effects</term>
<term>Uranyl acetate</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: Amiodarone, an antiarrhythmic drug, like chloroquine and chlorpromazine, is a tertiary amine with amphiphilic properties. Chloroquine and chlorpromazine are known inhibitors of phospholipases. All three drugs produce characteristic microcorneal deposits consistent with lysosomal accumulations of phospholipid. Similar lysosomal bodies were found in leukocytes of 15 patients on chronic amiodarone treatment as well as 3 patients each on chloroquine and chlorpromazine, suggestive of widespread systemic inhibition of lysosomal phospholipases. These lysosomal inclusions were similar in morphology, irrespective of the drug given, and were of four types: multilamellar, amorphous dense, amorphous light, or a combination of 2 or more of the preceding types. There was no simple relationship between the number of inclusion bodies per cell and the cumulative dose of amiodarone (r=0.02) or amiodarone serum levels (r=0.11). An in vitro assay was used to compare the effects of the three drugs on Ca2+-dependent phospholipase A and C activities. Phospholipase A2 activity was inhibited in a dose-dependent fashion (1–8 mg/assay) by all three drugs in the order: chlorpromazine > amiodarone > chloroquine. The inhibitory effect on phospholipase C was more pronounced with all three drugs, producing almost total inhibition at 8 mg/assay. In a Ca2+-independent lysosomal phospholipase A system, amiodarone had a greater effect, producing 85% inhibition at 1.2 mg/assay. These observations suggest that amiodarone, like other cationic amphiphiles, induces a generalized phospholipidosis by inhibiting phospholipid catabolism. Its therapeutic and toxic effects may be due to its ability to modulate both Ca2+-dependent membrane phospholipases and Ca2+-independent acid phospholipases.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Ontario</li>
</region>
<settlement>
<li>Toronto</li>
</settlement>
<orgName>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Ontario">
<name sortKey="Shaikh, Nisar A" sort="Shaikh, Nisar A" uniqKey="Shaikh N" first="Nisar A." last="Shaikh">Nisar A. Shaikh</name>
</region>
<name sortKey="Butany, Jagdish" sort="Butany, Jagdish" uniqKey="Butany J" first="Jagdish" last="Butany">Jagdish Butany</name>
<name sortKey="Downar, Eugene" sort="Downar, Eugene" uniqKey="Downar E" first="Eugene" last="Downar">Eugene Downar</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003359 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003359 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:FBB5BAE4DE480A524BAE62C540F26AAAB94B5FA1
   |texte=   Amiodarone — an inhibitor of phospholipase activity: a comparative study of the inhibitory effects of amiodarone, chloroquine and chlorpromazine
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021